What does the published scientific research say about Metschnikowia fructicola?

Eight peer-reviewed PubMed articles reference Metschnikowia fructicola in a plant-input context. First described as a new ascosporic yeast isolated from Israeli grapevines — and recognized as a sister species of M. pulcherrima — this yeast has been a subject of scientific literature on biocontrol yeasts for postharvest and field disease management across multiple crops.

Peer-reviewed research reports M. fructicola activity against Botrytis cinerea gray mold in vineyards, Penicillium expansum in apple wounds, and Penicillium digitatum on citrus peel. One study found M. fructicola biocontrol efficacy against B. cinerea was highest at 15–20°C, with performance tied closely to temperature and environmental conditions at application. A transcriptome analysis cited in the literature identified gene expression changes when M. fructicola interacts with a postharvest pathogen versus fruit tissue directly, offering molecular insight into how this yeast operates as a biocontrol agent.

The literature also documents that M. fructicola (strain NRRL Y-27328, sold commercially as NOLI) has been registered as a biocontrol product. Biocontrol yeast reviews note it among a small group with commercial registration precedent, while also flagging limited biosafety concerns and the relative scarcity of fundamental mechanistic studies on yeast biocontrol overall.